“Achievements of Polish Biopharmaceutical Companies: Bridging Science and Innovation” and “The New Wave of Polish Biotech: Emerging Non-Academic Start-ups and Spin-offs” were among the inspiring sessions at Eurobiotech 2026, where Adamed Discovery was proud to contribute to the dialogue connecting science and business in the life sciences sector.

Our Team – Michał Szymanik, Damian Graczyk and Jacek Banach – represented Adamed Discovery throughout the conference. Michał Szymanik chaired both scientific sessions, presented the progress of ONCO51 (ADO-51), the first anticancer protein developed in Poland currently in Phase I clinical trials, and participated in a panel discussion on future skills in biotechnology.  At our exhibition booth, the Team engaged with conference participants, showcasing Adamed R&D activities and Labgears, our knowledge management platform supporting research and development.

Thank you to the Organizers and everyone who visited our booth and joined the discussions. We look forward to continuing to foster innovation and collaboration across the life sciences community.